Bausch + Lomb (NYSE:BLCO) Given New $18.00 Price Target at Barclays

Bausch + Lomb (NYSE:BLCO – Get Rating) had its target price hoisted by Barclays from $17.00 to $18.00 in a research report report published on Friday morning, The Fly reports. Several other equities research analysts also recently weighed in on BLCO. Deutsche Bank Aktiengesellschaft upped their target price on shares of Bausch + Lomb from […]

Related Keywords

Canada , ,Jpmorgan Chase Co ,Deutsche Bank Aktiengesellschaft ,National Bank ,Lomb Corporation ,Tower Research Capital ,Royal Bank ,Barclays Plc ,Barclays ,Vision Care Consumer Health ,Ophthalmic Pharmaceuticals ,Morgan Stanley ,Get Rating ,Bank Aktiengesellschaft ,Moderate Buy ,Lomb Price ,Consumer Health Care ,Lomb Daily ,Bausch Lomb ,Nyse Blco ,Blco ,Medical ,Boost Price Target ,